Neogen Corp. Company Profile (NASDAQ:NEOG)

About Neogen Corp.

Neogen Corp. logoNeogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. It also provides genomic identification and related interpretive bioinformatics services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in control of rodents, insects and disease in and around agricultural, food production and other facilities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: NEOG
  • CUSIP: 64049110
Key Metrics:
  • Previous Close: $51.77
  • 50 Day Moving Average: $55.67
  • 200 Day Moving Average: $53.67
  • 52-Week Range: $43.79 - $61.24
  • Trailing P/E Ratio: 52.83
  • Foreward P/E Ratio: 39.26
  • P/E Growth: 2.79
  • Market Cap: $1.95B
  • Outstanding Shares: 37,709,000
  • Beta: 1.41
  • Net Margins: 11.25%
  • Return on Equity: 9.36%
  • Return on Assets: 8.35%
  • Current Ratio: 8.23%
  • Quick Ratio: 6.09%
Additional Links:
Companies Related to Neogen Corp.:

Analyst Ratings

Consensus Ratings for Neogen Corp. (NASDAQ:NEOG) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $56.33 (8.71% upside)

Analysts' Ratings History for Neogen Corp. (NASDAQ:NEOG)
DateFirmActionRatingPrice TargetDetails
8/29/2016Craig HallumDowngradeBuy -> HoldView Rating Details
3/24/2016Roth CapitalReiterated RatingBuyView Rating Details
3/25/2016Janney Montgomery ScottLower Price TargetNeutral$52.00View Rating Details
12/22/2015William BlairReiterated RatingMarket PerformView Rating Details
3/17/2015StephensDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 10/28/2014 forward)


Earnings History for Neogen Corp. (NASDAQ:NEOG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/27/2016Q117$0.26$0.26$83.65 millionViewListenView Earnings Details
7/19/2016Q416$0.26$0.26$86.27 million$90.10 millionViewListenView Earnings Details
3/23/2016Q3$0.25$0.22$78.47 million$76.73 millionViewListenView Earnings Details
12/21/2015Q216$0.26$0.24$79.60 millionViewListenView Earnings Details
9/21/2015Q116$0.27$0.25$74.90 millionViewListenView Earnings Details
7/21/2015Q4$0.24$0.25$76.50 million$78.60 millionViewListenView Earnings Details
3/26/2015Q315$0.23$0.20$70.60 million$68.40 millionViewN/AView Earnings Details
12/18/2014Q215$0.22$0.21$68.46 millionViewN/AView Earnings Details
9/22/2014Q115$0.23$0.24$67.60 millionViewN/AView Earnings Details
7/22/2014Q414$0.22$0.20$66.36 million$67.30 millionViewN/AView Earnings Details
3/25/2014Q314$0.18$0.18$60.38 million$62.00 millionViewN/AView Earnings Details
12/19/2013Q2$0.21$0.17$58.32 million$59.60 millionViewListenView Earnings Details
9/24/2013Q114$0.32$0.32$56.15 million$58.55 millionViewN/AView Earnings Details
7/23/2013Q4 2013$0.30$0.29$54.94 million$56.01 millionViewN/AView Earnings Details
3/26/2013Q3 2013$0.27$0.27$50.84 million$51.06 millionViewN/AView Earnings Details
12/20/2012Q2 2013$0.27$0.28$51.14 million$50.74 millionViewN/AView Earnings Details
9/25/2012Q113$0.27$0.28$51.42 million$49.73 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
3/27/2012$0.22$0.22ViewN/AView Earnings Details
12/22/2011$0.26$0.22ViewN/AView Earnings Details
9/27/2011$0.26$0.25ViewN/AView Earnings Details
7/26/2011$0.24$0.25ViewN/AView Earnings Details
3/22/2011$0.21$0.21ViewN/AView Earnings Details
1/4/2011$0.26$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Neogen Corp. (NASDAQ:NEOG)
Current Year EPS Consensus Estimate: $1.12 EPS
Next Year EPS Consensus Estimate: $1.32 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.24$0.24$0.24
Q2 20162$0.22$0.27$0.25
Q3 20161$0.25$0.25$0.25
Q4 20161$0.27$0.27$0.27
Q1 20172$0.26$0.26$0.26
Q2 20172$0.28$0.30$0.29
Q3 20171$0.28$0.28$0.28
Q4 20171$0.33$0.33$0.33
(Data provided by Zacks Investment Research)


Dividend History for Neogen Corp. (NASDAQ:NEOG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Neogen Corp. (NASDAQ:NEOG)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 86.74%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2016James L HerbertCEOSell12,000$55.22$662,640.00View SEC Filing  
9/30/2016Steven J QuinlanCFOSell3,000$55.15$165,450.00View SEC Filing  
9/29/2016Terri A MorricalVPSell9,600$54.14$519,744.00View SEC Filing  
8/24/2016Richard E. Calk, Jr.COOSell5,425$57.47$311,774.75View SEC Filing  
8/10/2016Jack C ParnellDirectorSell5,000$56.87$284,350.00View SEC Filing  
8/9/2016James L HerbertCEOSell6,068$55.60$337,380.80View SEC Filing  
8/8/2016James L HerbertCEOSell8,619$55.24$476,113.56View SEC Filing  
8/5/2016James L HerbertCEOSell24,070$55.41$1,333,718.70View SEC Filing  
8/4/2016James L HerbertCEOSell8,393$55.13$462,706.09View SEC Filing  
8/1/2016Edward BradleyVPSell20,196$55.60$1,122,897.60View SEC Filing  
5/19/2016Richard T CrowderDirectorSell27,250$48.05$1,309,362.50View SEC Filing  
5/10/2016Jack C ParnellDirectorSell4,000$49.17$196,680.00View SEC Filing  
3/24/2016Steven J QuinlanCFOBuy2,236$44.73$100,016.28View SEC Filing  
3/17/2016James L HerbertCEOSell2,500$49.05$122,625.00View SEC Filing  
3/3/2016James L HerbertCEOSell2,500$50.53$126,325.00View SEC Filing  
2/17/2016James L HerbertCEOSell2,500$48.73$121,825.00View SEC Filing  
2/16/2016James L. HerbertCEOSell31,500$48.02$1,512,630.00View SEC Filing  
2/3/2016James L HerbertCEOSell2,500$51.10$127,750.00View SEC Filing  
1/29/2016Terri A MorricalVPSell4,677$51.13$239,135.01View SEC Filing  
1/28/2016Jack C ParnellDirectorBuy13$50.25$653.25View SEC Filing  
1/19/2016James L HerbertCEOSell2,500$52.19$130,475.00View SEC Filing  
1/4/2016James L HerbertCEOSell7,500$54.24$406,800.00View SEC Filing  
12/17/2015James L HerbertCEOSell2,500$59.21$148,025.00View SEC Filing  
12/3/2015James L HerbertCEOSell7,500$59.02$442,650.00View SEC Filing  
11/17/2015James L HerbertCEOSell2,500$55.57$138,925.00View SEC Filing  
11/13/2015James L. HerbertCEOSell36,000$54.41$1,958,760.00View SEC Filing  
11/6/2015Edward BradleyVPSell15,700$55.62$873,234.00View SEC Filing  
11/5/2015Edward BradleyVPSell20,000$55.50$1,110,000.00View SEC Filing  
11/4/2015Edward BradleyVPSell24,300$55.97$1,360,071.00View SEC Filing  
11/3/2015James L HerbertCEOSell7,500$54.31$407,325.00View SEC Filing  
10/19/2015James L HerbertCEOSell2,500$48.40$121,000.00View SEC Filing  
10/5/2015James L HerbertCEOSell2,500$45.47$113,675.00View SEC Filing  
9/22/2015Steven J QuinlanCFOBuy1,060$47.17$50,000.20View SEC Filing  
9/22/2015Thomas H ReedDirectorBuy4,000$47.80$191,200.00View SEC Filing  
9/17/2015James L HerbertCEOSell7,500$54.11$405,825.00View SEC Filing  
9/3/2015James L HerbertCEOSell2,500$51.15$127,875.00View SEC Filing  
8/24/2015Edward BradleyVPSell5,100$51.00$260,100.00View SEC Filing  
8/24/2015James L. HerbertCEOSell11,148$51.36$572,561.28View SEC Filing  
8/17/2015G Bruce PapeshDirectorSell6,750$54.32$366,660.00View SEC Filing  
8/17/2015James L HerbertCEOSell2,500$57.71$144,275.00View SEC Filing  
7/22/2015James L HerbertCEOSell10,000$59.29$592,900.00View SEC Filing  
7/22/2015Steven J QuinlanCFOSell4,500$59.76$268,920.00View SEC Filing  
7/22/2015Terri A MorricalVPSell19,051$58.61$1,116,579.11View SEC Filing  
7/22/2015Thomas H ReedDirectorSell4,000$61.99$247,960.00View SEC Filing  
6/1/2015James L HerbertCEOSell5,000$46.83$234,150.00View SEC Filing  
4/22/2015James L HerbertCEOSell26,000$47.01$1,222,260.00View SEC Filing  
4/20/2015Richard E Calk JrCOOBuy5,425$45.84$248,682.00View SEC Filing  
4/1/2015James L HerbertCEOSell5,000$45.68$228,400.00View SEC Filing  
3/30/2015Edward BradleyVPSell44,372$47.02$2,086,371.44View SEC Filing  
2/19/2015Steven J QuinlanCFOSell1,500$48.70$73,050.00View SEC Filing  
1/2/2015G Bruce PapeshDirectorSell6,750$48.71$328,792.50View SEC Filing  
10/31/2014Terri A MorricalVPSell10,000$44.05$440,500.00View SEC Filing  
8/28/2014James L HerbertCEOSell14,829$41.98$622,521.42View SEC Filing  
8/25/2014Edward BradleyVPSell7,198$43.39$312,321.22View SEC Filing  
7/29/2014James L HerbertCEOSell10,000$44.17$441,700.00View SEC Filing  
4/1/2014Edward BradleyVPSell41,022$45.13$1,851,322.86View SEC Filing  
3/26/2014Terri MorricalVPSell13,950$45.37$632,911.50View SEC Filing  
2/7/2014James HerbertCEOSell25,000$39.57$989,250.00View SEC Filing  
11/21/2013Steven QuinlanCFOSell1,500$48.82$73,230.00View SEC Filing  
11/15/2013James HerbertCEOSell17,720$46.61$825,929.20View SEC Filing  
11/13/2013James HerbertCEOSell10,000$46.52$465,200.00View SEC Filing  
11/12/2013Clayton YeutterDirectorSell1,000$46.91$46,910.00View SEC Filing  
11/12/2013James HerbertCEOSell10,000$46.90$469,000.00View SEC Filing  
11/12/2013Lon BohannonCOOSell14,080$46.89$660,211.20View SEC Filing  
11/11/2013Lon BohannonCOOSell7,520$47.63$358,177.60View SEC Filing  
11/6/2013Clayton YeutterDirectorSell1,000$47.83$47,830.00View SEC Filing  
10/10/2013Edward BradleyVPSell9,380$61.03$572,461.40View SEC Filing  
8/21/2013Lon M BohannonCOOSell7,799$54.24$423,017.76View SEC Filing  
8/20/2013Edward BradleyVPSell4,499$53.80$242,046.20View SEC Filing  
8/20/2013James L HerbertCEOSell8,002$53.95$431,707.90View SEC Filing  
8/15/2013Terri A MorricalVPSell4,349$56.46$245,544.54View SEC Filing  
8/13/2013Lon M BohannonCOOSell22,000$57.10$1,256,200.00View SEC Filing  
8/9/2013Lon M BohannonCOOSell23,447$57.26$1,342,575.22View SEC Filing  
8/5/2013Lon M BohannonCOOSell28,304$57.31$1,622,102.24View SEC Filing  
8/1/2013Lon M BohannonCOOSell23,127$56.85$1,314,769.95View SEC Filing  
7/31/2013Lon M BohannonCOOSell25,252$56.56$1,428,253.12View SEC Filing  
7/30/2013James L HerbertCEOSell15,295$56.16$858,967.20View SEC Filing  
7/29/2013Lon M BohannonCOOSell10,546$56.80$599,012.80View SEC Filing  
7/26/2013Lon M BohannonInsiderSell12,771$57.22$730,756.62View SEC Filing  
5/9/2013Jack C ParnellDirectorSell3,619$52.50$189,997.50View SEC Filing  
12/28/2012Lon M BohannonCOOSell15,576$44.88$699,050.88View SEC Filing  
12/28/2012Terri A MorricalVPSell8,600$44.81$385,366.00View SEC Filing  
12/27/2012Lon M BohannonCOOSell20,594$45.75$942,175.50View SEC Filing  
12/26/2012Lon M BohannonCOOSell25,916$45.54$1,180,214.64View SEC Filing  
10/18/2012A. Charles FischerDirectorBuy1,000$42.49$42,490.00View SEC Filing  
10/4/2012James L HerbertCEOSell15,000$42.81$642,150.00View SEC Filing  
8/9/2012Lon M BohannonCOOSell21,601$39.17$846,111.17View SEC Filing  
8/8/2012Terri A MorricalVPSell2,551$39.97$101,963.47View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Neogen Corp. (NASDAQ:NEOG)
News IconNeogen Selected to Improve Scotland Beef Herd Genetics (NASDAQ:NEOG) - October 27 at 11:16 AM
News IconNeogen selected by Scottish Gov't for beef herd improvement program (NASDAQ:NEOG) - October 27 at 11:16 AM logoNeogen : $37,440 Federal Contract Awarded to Neogen (NASDAQ:NEOG) - October 19 at 6:43 PM
News IconUpdate on Neogen Corp. (NASDAQ:NEOG) for the day (NASDAQ:NEOG) - October 14 at 6:08 PM logoNEOGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:NEOG) - October 7 at 6:06 PM logoNeogen Corporation (NASDAQ:NEOG) Trading Down – Insiders Selling, Short Interest Growing (NASDAQ:NEOG) - October 4 at 11:05 AM
News IconNeogen and CRV partner to deliver health and efficiency traits (NASDAQ:NEOG) - October 3 at 5:58 PM logoNeogen now guarantees 17-day results for dairy genomic tests (NASDAQ:NEOG) - October 3 at 10:56 AM logoForm 4 NEOGEN CORP For: Sep 28 Filed by: MORRICAL TERRI A (NASDAQ:NEOG) - October 1 at 11:43 AM logoNEOGEN CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:NEOG) - September 30 at 6:29 PM
News IconPost Earnings Coverage as Neogen Reports Record Q1 Earnings and Revenue (NASDAQ:NEOG) - September 30 at 11:36 AM logoETF’s with exposure to Neogen Corp. : September 29, 2016 (NASDAQ:NEOG) - September 29 at 11:31 AM logoEdited Transcript of NEOG earnings conference call or presentation 27-Sep-16 3:00pm GMT (NASDAQ:NEOG) - September 28 at 11:22 AM logoNeogen Corp. breached its 50 day moving average in a Bearish Manner : NEOG-US : September 28, 2016 (NASDAQ:NEOG) - September 28 at 11:22 AM logoNeogen Corp. :NEOG-US: Earnings Analysis: Q1, 2017 By the Numbers : September 28, 2016 (NASDAQ:NEOG) - September 28 at 11:22 AM logoNeogen tops 1Q profit forecasts (NASDAQ:NEOG) - September 27 at 10:57 AM logoNeogen reports 12% revenue increase (NASDAQ:NEOG) - September 27 at 10:57 AM logoNeogen Corporation : quaterly earnings release (NASDAQ:NEOG) - September 22 at 6:02 PM logoNeogen Corporation (NASDAQ:NEOG) Rating At 2.6 (NASDAQ:NEOG) - September 19 at 10:52 AM logoNeogen Corp. (NEOG) Announces Receipt of AOAC Approval for AccuPoint (NASDAQ:NEOG) - September 19 at 10:52 AM logoNeogen's AccuPoint® Advanced receives AOAC approval (NASDAQ:NEOG) - September 19 at 10:52 AM logoNeogen’s AccuPoint® Advanced receives AOAC approval (NASDAQ:NEOG) - September 19 at 10:52 AM logoBRIEF-Neogen's Accupoint Advanced receives AOAC approval (NASDAQ:NEOG) - September 19 at 9:19 AM logoNeogen Corp. – Value Analysis (NASDAQ:NEOG) : September 14, 2016 (NASDAQ:NEOG) - September 14 at 6:28 PM logoNeogen Corp. breached its 50 day moving average in a Bullish Manner : NEOG-US : September 13, 2016 (NASDAQ:NEOG) - September 13 at 11:11 AM logoETF’s with exposure to Neogen Corp. : September 9, 2016 (NASDAQ:NEOG) - September 9 at 6:02 PM
News IconNeogen launches ThyroKare Equine Powder (NASDAQ:NEOG) - August 30 at 9:44 AM logoNeogen : launches ThyroKare™ Equine Powder (NASDAQ:NEOG) - August 30 at 9:44 AM logoNeogen launches ThyroKare™ Equine Powder (NASDAQ:NEOG) - August 29 at 10:54 AM logoCan Neogen Corporation (NASDAQ:NEOG) Meet Analysts Expectations? (NASDAQ:NEOG) - August 28 at 10:31 AM logoETF’s with exposure to Neogen Corp. : August 23, 2016 (NASDAQ:NEOG) - August 23 at 6:36 PM
News IconNeogen unveils AOAC-validated Campylobacter test (NASDAQ:NEOG) - August 16 at 9:43 AM logoForm 4 NEOGEN CORP For: Aug 08 Filed by: HERBERT JAMES L (NASDAQ:NEOG) - August 10 at 6:51 PM logoNEOGEN CORP Financials (NASDAQ:NEOG) - August 4 at 6:46 PM logoNeogen launches AccuClean® Advanced rapid protein test (NASDAQ:NEOG) - August 3 at 6:44 PM logoNeogen adds to its easy-to-use culture media packaging (NASDAQ:NEOG) - August 3 at 6:44 PM logoNeogen launches ANSR® for Campylobacter (NASDAQ:NEOG) - August 3 at 6:44 PM logoNeogen launches rapid test for 6-acetylmorphine (6-AM) (NASDAQ:NEOG) - August 1 at 6:08 PM logoNEOGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) (NASDAQ:NEOG) - July 30 at 9:16 AM logoNEOGEN CORP Files SEC form 10-K, Annual Report (NASDAQ:NEOG) - July 29 at 2:02 PM logoNEOGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:NEOG) - July 27 at 2:01 PM logoGlobal Farm Animal Diagnostics Market 2016 Share, Trend, Segmentation and Forecast to 2022 (NASDAQ:NEOG) - July 26 at 9:38 AM logoETF’s with exposure to Neogen Corp. : July 25, 2016 (NASDAQ:NEOG) - July 25 at 1:34 PM
News IconNew report shares details about the animal genetics market that is projected to reach 5.50 billion USD by 2021 (NASDAQ:NEOG) - July 22 at 6:18 PM logoNeogen Corp. :NEOG-US: Earnings Analysis: Q4, 2016 By the Numbers : July 22, 2016 (NASDAQ:NEOG) - July 22 at 11:19 AM logoNeogen Corp. :NEOG-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 (NASDAQ:NEOG) - July 22 at 9:06 AM logoNeogen (NEOG) Q4 Earnings and Revenues Increase Y/Y (NASDAQ:NEOG) - July 21 at 8:15 AM logoNEOG Crosses Above Average Analyst Target (NASDAQ:NEOG) - July 20 at 9:23 AM logoNEOGEN CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:NEOG) - July 20 at 9:23 AM
News IconNeogen reports record revenues and earnings (NASDAQ:NEOG) - July 20 at 9:23 AM


Neogen Corp. (NASDAQ:NEOG) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff